Astera Labs (NASDAQ:ALAB) Stock Price Up 7.6% - Here's Why

Key Points

• Astera Labs shares jumped 7.6% to $389.80, with trading volume about 25% above its daily average.
• Analysts raised several price targets, including Jefferies and Roth Capital to $450, while the stock carries a “Moderate Buy” consensus rating and an average target of $348.33.
• The company recently beat quarterly expectations with $0.80 in EPS versus $0.69 expected and revenue of $392.4 million, up 104.5% year over year.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shot up 7.6% on Tuesday. The company traded as high as $401.74 and last traded at $389.80. Approximately 6,489,137 shares were traded during mid-day trading, an increase of 25% from the average daily volume of 5,191,556 shares. The stock had previously closed at $362.34.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ALAB shares. Susquehanna lifted their price target on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a research report on Friday, July 31st. Jefferies Financial Group lifted their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a research report on Wednesday, August 5th. Zacks Research raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 11th. Roth Capital reissued a "buy" rating and issued a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Finally, UBS Group restated a "neutral" rating and set a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $348.33.

Astera Labs Trading Up 7.6%

The stock has a 50 day simple moving average of $310.63 and a 200 day simple moving average of $284.74. The firm has a market capitalization of $67.62 billion, a PE ratio of 192.97 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm's revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 90,630 shares of the company's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the firm's stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares of the company's stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 396,059 shares of company stock worth $122,605,660 over the last 90 days. 10.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Astera Labs

Several institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. purchased a new position in shares of Astera Labs during the second quarter valued at about $6,609,581,000. ABS Investment Management LLC bought a new stake in Astera Labs during the 2nd quarter valued at approximately $1,980,382,000. Van ECK Associates Corp grew its holdings in shares of Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock worth $1,080,980,000 after acquiring an additional 373,545 shares during the period. Bank of America Corp DE purchased a new position in shares of Astera Labs during the 2nd quarter worth approximately $1,061,791,000. Finally, Atreides Management LP bought a new position in shares of Astera Labs in the 2nd quarter worth approximately $587,736,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.